awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33358448-2EF705AB-A2D9-4FFE-87EA-6D8551C91DB8
Q33358448-2EF705AB-A2D9-4FFE-87EA-6D8551C91DB8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33358448-2EF705AB-A2D9-4FFE-87EA-6D8551C91DB8
Randomised phase II study of docetaxel/cisplatin vs docetaxel/irinotecan in advanced non-small-cell lung cancer: a West Japan Thoracic Oncology Group Study (WJTOG9803).
P2860
Q33358448-2EF705AB-A2D9-4FFE-87EA-6D8551C91DB8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33358448-2EF705AB-A2D9-4FFE-87EA-6D8551C91DB8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9b768e3baf6bf9a71becf3fc4a37cf53c72e9ccb
P2860
Paclitaxel plus carboplatin, compared with paclitaxel plus gemcitabine, shows similar efficacy while more cost-effective: a randomized phase II study of combination chemotherapy against inoperable non-small-cell lung cancer previously untreated.